Travere Therapeutics Inc

Research Travere Therapeutics Inc (TVTX) on Bullrun: market cap USD 5.42B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTVTX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.42B
• Financial periodFY2025
• RevenueUSD 490.73M
• Revenue growth110.5%
• Net income-USD 25.55M
• Gross margin97.9%

Valuation Snapshot

latest market cap is USD 5.42B.

About Travere Therapeutics Inc

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company's products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II);

Frequently asked questions

What is Travere Therapeutics Inc's market cap?

Travere Therapeutics Inc's market capitalization is USD 5.42B.

What does Travere Therapeutics Inc do?

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.